This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
research:protocols_in_development [2017/04/16 08:57] burculantonija |
research:protocols_in_development [2019/10/17 17:03] mary_regina_boland |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Protocols under Development ====== | ====== Protocols under Development ====== | ||
- | * [[research:pgx_drug_exposure|Incidence of exposure to PGx drug]] | + | We currently in the process of consolidating all OHDSI study materials on the OHDSI github and will be retiring this wiki page shortly. If you have study materials on the OHDSI wiki, please move them here: https://github.com/OHDSI/StudyProtocolSandbox |
- | * [[research:Learning Effective Clinical Treatment Pathways from Data| Learning Effective Clinical Treatment Pathways from Data ]] | + | |
- | * [[research:project_proposal_template_2|Investigation of global incidence and outcome of sudden cardiac arrest]] | + | |
- | * [[research:Concordance with AAD guidelines for the treatment of acne vulgaris|Concordance with AAD guidelines for the treatment of acne vulgaris]] | + | |
- | * [[research:comparison_of_combination_treatment_in_hypertension|Comparison of combination treatment in hypertension]] | + | |
- | * [[research:large-scale modeling of patients with thyroid conditions|Large-scale modeling of patients with thyroid conditions]] | + | |
+ | All new studies should be posted is the OHDSI Github Study Protocol Sandbox. Please DO NOT post new study materials on this wiki page. | ||
+ | |||
+ | * [[research:project_proposal_template_2|Investigation of global incidence and outcome of sudden cardiac arrest]] | ||
+ | * [[research:Characterization of Oral Antibiotics for Acne Treatment]] | ||
+ | * [[research:CancerStudy|Treatments in cancer]] | ||
+ | * [[research:all_by_all_incidence|How Often? All-by-all Drug-Condition Incidence Rate]] | ||
+ | * [[research: Risk of acute kidney injury between conventional NSAIDs and selective COX-2 inhibitors]] | ||
+ | * [[research: Comparison of pathologic bone fracture risk between between Tenofovir and Entecavir in chronic hepatitis B patients]] | ||
+ | * [[research:OHDSI Perioperative Prediction: Development and Validation of Prognostic Prediction models for Post-Operative Outcomes of Interest|OHDSI Perioperative Prediction: Development and Validation of Prognostic Prediction models for Post-Operative Outcomes of Interest]] | ||
- | | ||
- | * [[research:project_proposal_template_3|New Study Template]] |